Biocon

In News

Biocon Receives Health Canada Approval of Bosaya™ (Denosumab) and Vevzuo™ (Denosumab), Biosimilars to Prolia - Business Wire

Business Wire - Apr 21, 2026

Biocon Secures Health Canada Nod for Denosumab Biosimilars Bosaya, Vevzuo - Medical Dialogues

Medical Dialogues - Apr 21, 2026

Biocon receives Health Canada approval for Bosaya and Vevzuo biosimilars - marketscreener.com

marketscreener.com - Apr 21, 2026

Biocon gets notice of compliance from Health Canada for two biosimilars - BusinessLine

BusinessLine - Apr 21, 2026

7 Stocks to Buy for Short Term: Brokerages bullish on M&M, Biocon and others with upto 55% upside potential; check full list - Zee Business

Zee Business - Apr 21, 2026

Biocon's Breakthrough: Bosaya and Vevzuo Approved by Health Canada - Devdiscourse

Devdiscourse - Apr 21, 2026

Biocon gains after Health Canada nod for cancer, osteoporosis drugs - CNBC TV18

CNBC TV18 - Apr 21, 2026

Health Canada Approves Biocon's Denosumab Biosimilars for Osteoprosis, Cancer-Related Bone Conditons - ANI News

ANI News - Apr 21, 2026

Biocon rises after Health Canada grants NOC for Denosumab biosimilars - Business Standard

Business Standard - Apr 21, 2026

Biocon shares rise after Health Canada approves Bosaya and Vevzuo - NewsBytes

NewsBytes - Apr 21, 2026

‘Scale Matters And Portfolio Matters’ – Biocon’s Erick On The US Biosimilars Market - Citeline News & Insights

Citeline News & Insights - Apr 14, 2026

Biocon trims workforce as Biologics merger nears completion - Moneycontrol.com

Moneycontrol.com - Mar 31, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment